Phytoconstituents, In Vitro Anti-Infective Activity of Buddleja indica Lam., and In Silico Evaluation of its SARS-CoV-2 Inhibitory Potential

Título

Phytoconstituents, In Vitro Anti-Infective Activity of Buddleja indica Lam., and In Silico Evaluation of its SARS-CoV-2 Inhibitory Potential

Autor

Fadia S. Youssef, Ahmed E. Altyar, Abdelsattar M. Omar, Abdelsattar M. Omar, Mohamed L. Ashour, Mohamed L. Ashour

Descripción

Phytochemical investigation of Buddleja indica Lam. leaves methanol extract (BIT) resulted in the isolation of six known compounds for the first time from the plant, namely, p-hydroxybenzoic acid 1), caffeic acid 2), quercetin 3-O-β-D glucoside-7-O-α-L-rhamnoside 3), kaempferol 3-O-β-D glucoside-7-O-α-L-rhamnoside 4), quercetin 7-O-β-D glucoside 5) and kaempferol 6). BIT extract showed potent antibacterial activity with MIC values ranging between 0.48 and 1.95 μg/ml with Bacillus subtilis was the most susceptible to the BIT effect. It showed a notable antimycobacterial and anti-Helicobacter pylori activity with MIC values of 100 and 80 μg/ml, respectively. Vesicular stomatitis virus (VSV) was more sensitive to the antiviral activity of BIT comparable to herpes simplex virus type 1 (HSV-1), showing 48.38 and 41.85% inhibition of the viral replication at a dose of 50 μg/ml for VSV and HSV-1, respectively. In silico molecular docking of the isolated compounds revealed that caffeic acid 2) showed the highest fitting within the active sites of DNA-gyrase, topoisomerase IV, and SARS-CoV-2 MPro. Quercetin 7-O-β-D glucoside 5) revealed the best fitting in dihydrofolate reductase active site with ∆ G value equals −36.53 Kcal/mol. Kaempferol 6) exhibited the highest fitting towards β-lactamase, SARS-CoV-2PLpro, and SARS-CoV-2 3CLpro active sites. Thus, B. indica Lam. can be considered as a future source of cheap, substantially safe, and credible antibacterial, antifungal, and antiviral candidate of natural origin that could effectively participate in solving the problem of COVID-19 pandemic. These findings provide a scientific consolidation for the ethnomedicinal uses of Buddleja indica Lam. as a topical antiseptic.

Fecha

2021

Materia

antiviral, covid-19, molecular modeling, phytoconstituents, antimicrobial, Buddleia indica

Identificador

10.3389/fphar.2021.619373

Fuente

Epidemiology and Health

Editor

Korean Society of Epidemiology

Cobertura

Therapeutics. Pharmacology

Archivos

https://socictopen.socict.org/files/to_import/pdfs/38c82cb79820328b42e7c9d81cb4ec13.pdf

Colección

Citación

Fadia S. Youssef, Ahmed E. Altyar, Abdelsattar M. Omar, Abdelsattar M. Omar, Mohamed L. Ashour, Mohamed L. Ashour, “Phytoconstituents, In Vitro Anti-Infective Activity of Buddleja indica Lam., and In Silico Evaluation of its SARS-CoV-2 Inhibitory Potential,” SOCICT Open, consulta 17 de abril de 2026, https://www.socictopen.socict.org/items/show/9391.

Formatos de Salida

Position: 11129 (24 views)